CGTX Cognition Therapeutics Inc

USD 1.98 0.00 0
Icon

Cognition Therapeutics Inc (CGTX) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 1.98

0.00 (0.00)%

USD 0.08B

0.07M

USD 8.75(+341.92%)

USD 20.00 (+910.10%)

Icon

CGTX

Cognition Therapeutics Inc (USD)
COMMON STOCK | NSD
USD 1.98
0.00 0
Take a Tour
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 0.08B

USD 20.00 (+910.10%)

USD 1.98

Cognition Therapeutics Inc (CGTX) Stock Forecast

Show ratings and price targets of :
USD 8.75
(+341.92%)

Based on the Cognition Therapeutics Inc stock forecast from 4 analysts, the average analyst target price for Cognition Therapeutics Inc is USD 8.75 over the next 12 months. Cognition Therapeutics Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Cognition Therapeutics Inc is Bearish, which is based on 1 positive signals and 6 negative signals. At the last closing, Cognition Therapeutics Inc’s stock price was USD 1.98. Cognition Therapeutics Inc’s stock price has changed by +3.66% over the past week, -8.76% over the past month and +14.45% over the last year.

No recent analyst target price found for Cognition Therapeutics Inc
No recent average analyst rating found for Cognition Therapeutics Inc

Company Overview Cognition Therapeutics Inc

Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate is CT18...Read More

https://www.cogrx.com

2500 Westchester Avenue, Purchase, NY, United States, 10577

25

December

USD

USA

Adjusted Closing Price for Cognition Therapeutics Inc (CGTX)

Loading...

Unadjusted Closing Price for Cognition Therapeutics Inc (CGTX)

Loading...

Share Trading Volume for Cognition Therapeutics Inc Shares

Loading...

Compare Performance of Cognition Therapeutics Inc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for CGTX

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Cognition Therapeutics Inc (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
VRTX
Vertex Pharmaceuticals Inc 0.00 (0.00%) USD127.00B 31.94 20.00

ETFs Containing CGTX

Symbol Name CGTX's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Cognition Therapeutics Inc (CGTX) Stock

Based on ratings from 4 analysts Cognition Therapeutics Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Bearish. The stock has 4 buy, sell and hold ratings.

Unfortunately we do not have enough data on CGTX's stock to indicate if its a good dividend stock.

Based on targets from 4 analysts, the average taret price for CGTX is USD 8.75 over the next 12 months. The maximum analyst target price is USD 11 while the minimum anlayst target price is USD 5.

Unfortunately we do not have enough data on CGTX's stock to indicate if its overvalued.

The last closing price of CGTX's stock was USD 1.98.

The most recent market capitalization for CGTX is USD 0.08B.

Based on targets from 4 analysts, the average taret price for CGTX is projected at USD 8.75 over the next 12 months. This means that CGTX's stock price may go up by +341.92% over the next 12 months.

We can't find any ETFs which contains Cognition Therapeutics Inc's stock.

As per our most recent records Cognition Therapeutics Inc has 25 Employees.

Cognition Therapeutics Inc's registered address is 2500 Westchester Avenue, Purchase, NY, United States, 10577. You can get more information about it from Cognition Therapeutics Inc's website at https://www.cogrx.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...